AAVantgarde presents positive preclinical data in large anim

MILAN, Italy, April 23, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today

Related Keywords

United States , Italy , Milan , Lombardia , American , Italian , Aavantgarde Bio , Natalia Misciattelli , Alberto Auricchio , Magda Blanco , Telethon Institute Of Genetics , Head Of Corporate Development Aavantgarde , American Society Of Gene Cell Therapy , Telethon Foundation , Adeno Associated Viral , American Society , Cell Therapy , Annual Meeting , Friday May , Human Primates , Large Animal , Professor Alberto Auricchio , Telethon Institute , Corporate Development ,